Injection guidance: Standard subcutaneous technique applies
The ChaC family (ChaC1 and ChaC2, cytoplasmic glutathione-specific -glutamyl cyclotransferases) has recently been shown to take part in GSH metabolism
In Dec 2021, Shanghai Innogen Pharma successfully completed a $120 million Series A funding round to support its Phase III trial of supaglutide, a GLP-1 agonist targeting diabetes
What You Should Know: The Strategic Pivot Validated: Weight Watchers (WW) has released GLP-1 Results Report validating its integrated weight health platform, which combines medical therapy with behavioral support
The secondary end points included change in body weight and safety
Obesity is increasingly recognized as a chronic disease, and some legal experts warn that excluding coverage for obesity treatment while covering other chronic conditions could expose employers to litigation under the Americans with Disabilities Act or state anti-discrimination laws